Electromedical & Imaging Equipment Manufacturing in the UK: Market Size, Businesses & Forecast 2026

The Electromedical & Imaging Equipment Manufacturing industry in the UK encompasses the design and production of advanced medical diagnostic, therapeutic, and patient monitoring technologies. According to the Office for Life Sciences (OLS), the broader medical technology subsector, which contains these manufacturers, achieved a turnover of £48.0 billion across 4,360 companies in 2023/2024 (GOV.UK). The sector's trajectory is driven by an aging population and increasing NHS infrastructure demands, forcing domestic manufacturers to innovate within strict digital security and sovereign supply chain landscapes.

Industry snapshot

Key public data points

Historical & forecast

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

What does the Electromedical & Imaging Equipment Manufacturing in the UK industry cover?

This industry comprises establishments primarily engaged in manufacturing electromedical, irradiation, and electrotherapeutic apparatus. These products span critical diagnostic and surgical systems powered by electrical current or radiation. The production encompasses complex technical devices designed for both intensive clinical use and decentralized community care settings.

• •Covers key products including Magnetic Resonance Imaging (MRI) devices, computed tomography (CT) scanners, and position emission tomography (PET) systems.
• •Includes therapeutic and lifekeeping gear such as pacemakers, defibrillators, electrocardiographs, medical lasers, and endoscopic instruments.
• •Excludes non-electrical instruments, dental materials, or standard laboratory physical equipment.
• •Incorporates both physical hardware engineering and embedded software integration critical for device operation.

Who operates in the industry and how is it structured?

The UK market is characterized by a multi-tiered corporate structure combining specialized local entities with major global manufacturers. According to official data from the Office for Life Sciences, the overarching medical technology workforce totals 196,000 employees as of 2023/2024, making it the largest employer in the broader UK life sciences sector. Industry participants are dispersed regionally, with notable clusters located in the South East and Midlands.

• •The broader medical technology space encompasses 4,360 distinct companies in 2023/2024 (Office for Life Sciences).
• •Small and medium-sized enterprises (SMEs) comprise a significant percentage of unique operating entities, focusing on specialized niches.
• •The South East region accounts for approximately 24% of employment and 27% of overall turnover across the life sciences sector footprint.
• •Entities frequently engage in a hybrid business model where manufacturing is closely paired with contract research and experimental development.

What drives demand in the industry?

Domestic demand is structural and heavily insulated from typical macroeconomic downturns, given its connection to public healthcare provisions. The primary institutional driver is the National Health Service (NHS), which coordinates centralized procurement frameworks aimed at updating legacy scanning infrastructure. Furthermore, demographic shifts and long-term health trends create continuous demand for therapeutic advancements.

• •An aging population directly increases clinical incidence rates for age-related health issues, chronic illnesses, and multi-morbidity profiles.
• •According to the British Heart Foundation, over 7.6 million individuals in the UK were living with cardiovascular disease as of September 2025.
• •NHS long-term modernization strategies require ongoing capital allocation toward high-throughput diagnostic hubs and early-stage cancer screening equipment.
• •A shifting paradigm toward decentralized healthcare fuels demand for portable, remote patient monitoring devices and connected home care units.

Who are the notable companies in the industry?

The UK market includes several highly capitalized multinationals operating local manufacturing, assembly, or advanced research subsidiaries alongside domestic firms. Competition is driven by engineering superiority, clinical accuracy, and compliance speed rather than aggressive price cutting. Because the NHS favors value-based purchasing, operators must continuously validate the cost-efficiency of their tech portfolios.

• •Siemens Healthineers AG operates extensive local engineering and production infrastructure within the UK, specializing in diagnostic imaging lines.
• •Philips Electronics UK Limited maintains a deep presence across regional healthcare networks, focusing on monitoring and resuscitation systems.
• •GE Medical Systems Limited serves as a major provider of radiology, ultrasound, and healthcare digital application hardware.
• •Smiths Group plc, a prominent UK-headquartered public corporation, designs and manufactures specialized medical and delivery systems through its industrial segments.

What are the recent trends and outlook?

The sector is transitioning toward deep digital and autonomous integration within manufacturing and end-user device capabilities. Industry 4.0 techniques, localized additive manufacturing, and artificial intelligence diagnostic plugins represent the core focus of modern capital expenditure. Supply chains remain vulnerable to geopolitical shifts and electronic component logistics, motivating efforts toward domestic manufacturing resilience.

• •Artificial intelligence is increasingly integrated directly onto physical imaging hardware for rapid image processing and real-time clinical decisions.
• •Tariff environments and supply bottlenecks affect procurement costs for specialized sensors, imported imaging lenses, and raw precision instruments.
• •Environmental mandate pressures require manufacturers to optimize device lifecycles and create energy-efficient scanning units matching NHS net-zero goals.
• •Post-pandemic healthcare strategies stress the resilience of regional electromedical assembly plants to insulate against global transport shocks.

How is the industry regulated?

Regulatory frameworks governing electromedical equipment in the UK are strict and undergoing active evolution to manage data privacy and safety. Manufacturers must align with specialized quality standards to achieve market authorization and participate in public supply networks. The regulatory path directly dictates the commercial velocity of new equipment introductions.

• •The Medicines and Healthcare products Regulatory Agency (MHRA) serves as the primary executive arbiter for medical device validation and market placement in the UK.
• •Manufacturers must transition toward localized UK Conformity Assessed (UKCA) markings to replace historical CE marks on equipment lines.
• •Connected electromedical devices must adhere to rigorous NHS Digital data security standards, protecting patient infrastructure from cyber vulnerabilities.
• •Production environments require strict alignment with international quality management systems including ISO 13485 guidelines.

Government, statistical and trade sources used for this Claight analysis.

• Office for Life Sciences Bioscience and Health Technology Sector Statistics 2023 to 2024 ·
• Office for National Statistics UK Standard Industrial Classification (SIC) 2007 ·
• British Heart Foundation Cardiovascular Disease Statistics 2025